Drug interactions with complementary medicines

Australian Prescriber

Volumn 33, Issue 6, 2010, Pages 177-180

  Moses, Geraldine M ^a   McGuire, Treasure M ^b,c  

^a MATER HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c BOND UNIVERSITY   (Australia)

Author keywords

Drug interactions; St john's wort

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; CENTRAL DEPRESSANT AGENT; CLOPIDOGREL; CRATAEGUS EXTRACT; DIGOXIN; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GLIPIZIDE; GLUCOSAMINE; HYPERICUM PERFORATUM EXTRACT; IMATINIB; KAVA; NITRIC ACID DERIVATIVE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; ORAL CONTRACEPTIVE AGENT; PETHIDINE; PHOSPHODIESTERASE INHIBITOR; PRIMROSE OIL; SAQUINAVIR; TRAMADOL; TRIPTAN DERIVATIVE; UNINDEXED DRUG; WARFARIN;

ALTERNATIVE MEDICINE; ARTICLE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG POTENTIATION; HUMAN; PHARMACODYNAMICS; POLYPHARMACY; PRESCRIPTION; RISK ASSESSMENT;

EID: 78650141196     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2010.084     Document Type: Article

References (14)

1. Therapeutic Goods Administration. The regulation of complementary medicines in Australia - an overview. April 2006. www.tga.gov.au/cm/cmreg-aust.htm (information last reviewed 2007 Apr 24) [cited 2010 Nov 16]
2. Kotsirilos V. GPs' attitudes toward complementary medicine. Aust Fam Phys 2007;36:270-1.
3. Australian Bureau of Statistics. Australian Social Trends, 2008 Paper 4102.0. www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4102.0Chapter5202008 [cited 2010 Nov 16]
4. Nahin RL, Pecha M, Welmerink DB, Sink K, DeKosky ST, Fitzpatrick AL. Concomitant use of prescription drugs and dietary supplements in ambulatory elderly people. J Am Geriatr Soc 2009;57:1197-205.
5. Peng CC, Glassman PA, Trilli LE, Hayes-Hunter J, Good CB. Incidence and severity of potential drug-dietary supplement interactions in primary care patients: an exploratory study of 2 outpatient practices. Arch Intern Med 2004;164:630-6.
6. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300:2867-78.
7. Cadieux RJ. Drug interactions in the elderly. How multiple drug use increases risk exponentially. Postgrad Med 1989;86:179-86.
8. Boullata J. Natural health product interactions with medication. Nutr Clin Pract 2005;20:33-51.
9. Dietary supplements - a framework for evaluating safety. Institute of Medicine. Washington, DC: The National Academies Press; 2005. p. 235-46. www.nap.edu/books/0309091101/html [cited 2010 Nov 16]
10. MacGregor JT, Collins JM, Sugiyama Y, Tyson CA, Dean J, Smith L. In vitro human tissue models in risk assessment: report of a consensus-building workshop. Toxicol Sci 2001;59:17-36.
11. Jellin JM, editor. Natural medicines comprehensive database. Therapeutic Research Faculty, Stockton (CA), USA. www.naturaldatabase.com [cited 2010 Nov 16]
12. McGuire TM, Walters JA, Dean AJ, Van Driel M, Del Mar C, Kotsirilos V, et al. Review of the quality of complementary medicines information resources: summary report. Sydney: National Prescribing Service; 2009. www.nps.org.au/__data/assets/pdf_file/0005/69656/CMsInfoSummary.pdf [cited 2010 Nov 16]
13. Bjerrum L, Gonzalez Lopez-Valcarcel B, Petersen G. Risk factors for potential drug interactions in general practice. Eur J Gen Pract 2008;14:23-9.
14. Barnes J, Anderson LA, Phillipson JD. Herbal interactions. Pharm J 2003;270:118-21.